We propose that the AD risk factor APOEε4 promotes neuritic degeneration, resulting in the accumulation of pTau in axonal endings and synapses which may facilitate Tau-pathology progression, particularly toward Aβ-affected brain regions. Here, MAPT is linked to Alzheimer disease.